Veterinary Medicines Information website

Tilmovet 250 mg/ml Concentrate for oral solution

Authorised
  • Tilmicosin
Download as PDF

Product identification

Medicine name:
Tilmovet 250 mg/ml Concentrate for oral solution
Active substance:
  • Tilmicosin
Target species:
  • Pig
  • Turkey
  • Chicken
  • Cattle (calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Tilmicosin
    250.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        14
        day
    • Turkey
      • Meat and offal
        19
        day
    • Chicken
      • Meat and offal
        12
        day
    • Cattle (calf)
      • Meat and offal
        42
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA91
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • White high density polyethylene bottle with white polypropylene or high density polyethylene, tamper-evident cap
  • High density polyethylene (HDPE) bottle with a tamper-evident screw closure made of polypropylene (PP)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 41061
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0016/001
Concerned member states:
  • Austria
  • Bulgaria
  • Czechia
  • Denmark
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/03/2026
Download
Danish (, KONCENTRAT TIL ORAL OPLØSNING 250 MG-ML)
Published on: 7/04/2025
Download

Package Leaflet

English (PDF)
Published on: 13/03/2026
Download

Combined File of all Documents

English (PDF)
Published on: 13/03/2026
Download